ROTTERDAM, Netherlands and SAN DIEGO, May 25, 2022 /PRNewswire/ Today, SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage
/PRNewswire/ Today, SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage determination was.
The company believes its fixed-panel, informatically guided approach can help capture the most possible patients with signs of residual or recurring cancer.